Literature DB >> 8717555

Inadequacy of dipstick proteinuria in hypertensive pregnancy.

M A Brown1, M L Buddle.   

Abstract

The objective of this study was to determine the accuracy of ward urinalysis and the sensitivity of dipstick testing in the assessment of proteinuria in hypertensive pregnant women. Subjects were 230 consecutive hypertensive pregnant women who were admitted to hospital over a 2-year period. Routine ward urinalyses for protein, obtained on a mid-stream sample before and after a 24-hour urine collection for quantitating proteinuria, were compared with the 24-hour urine protein excretion. As a control for dipstick accuracy, urinalysis was also performed on a mixed aliquot of each of the 24-hour samples by a single observer experienced in urinalysis. True proteinuria was considered as > 300 mg/day. The positive predictive value for urinalysis ranged from 38% (for the precollection test) to 60% (for tests on the aliquot). Negative predictive values were 86-88%. The false negative rates at 'nil' or 'trace' proteinuria ranged from 8-18%. The false positive rates at '3+' (3 g/L) or '4+' (> or = 20 g/L) ranged from 0-17%, at '2+' (1 g/L) from 18-50% and at '1+' (0.3 g/L) from 67-83%. Best results for urinalysis were obtained on the aliquot testing but even under these ideal circumstances there was a high false positive rate (67%) at '1+' (0.3 g/L) urinalysis level. These studies show that in routine clinical practice 'nil' or 'trace' proteinuria will miss significant proteinuria in approximately 1 out of 8 hypertensive pregnant women while '3+' (3 g/L) or '4+' ( > or = 20 g/L) will rarely be a false positive. At urinalysis of '1+' or '2+' a 24-hour urine collection is required to be certain about the presence or absence of proteinuria. Research studies should demand 24-hour urine protein quantitation and not rely solely upon urinalysis results.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8717555     DOI: 10.1111/j.1479-828x.1995.tb02143.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  8 in total

1.  Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia.

Authors:  Irina A Buhimschi; Guomao Zhao; Edmund F Funai; Nathan Harris; Isaac E Sasson; Ira M Bernstein; George R Saade; Catalin S Buhimschi
Journal:  Am J Obstet Gynecol       Date:  2008-11       Impact factor: 8.661

2.  Urinalysis vs urine protein-creatinine ratio to predict significant proteinuria in pregnancy.

Authors:  B K Dwyer; M Gorman; I R Carroll; M Druzin
Journal:  J Perinatol       Date:  2008-02-21       Impact factor: 2.521

Review 3.  Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review.

Authors:  Anne-Marie Côté; Mark A Brown; Elaine Lam; Peter von Dadelszen; Tabassum Firoz; Robert M Liston; Laura A Magee
Journal:  BMJ       Date:  2008-04-10

4.  Diagnosis of hypertensive disorders of pregnancy in sub-Saharan Africa: a poorly assessed but increasingly important issue.

Authors:  Joël Fokom-Domgue; Jean Jacques N Noubiap
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-10-28       Impact factor: 3.738

5.  Maternal periodontal disease and preeclampsia in Jaipur population.

Authors:  Girija Jaiman; Prathibha Anand Nayak; Sanu Sharma; Kiran Nagpal
Journal:  J Indian Soc Periodontol       Date:  2018 Jan-Feb

Review 6.  Protein Misfolding during Pregnancy: New Approaches to Preeclampsia Diagnostics.

Authors:  Elizaveta M Gerasimova; Sergey A Fedotov; Daniel V Kachkin; Elena S Vashukova; Andrey S Glotov; Yury O Chernoff; Aleksandr A Rubel
Journal:  Int J Mol Sci       Date:  2019-12-07       Impact factor: 5.923

7.  Urinary protein-to-creatinine ratio in pregnant women after dipstick testing: prospective observational study.

Authors:  Yosuke Baba; Takahiro Yamada; Mana Obata-Yasuoka; Shun Yasuda; Yasumasa Ohno; Kosuke Kawabata; Shiori Minakawa; Chihiro Hirai; Hideto Kusaka; Nao Murabayashi; Yusuke Inde; Michikazu Nagura; Hiromi Hamada; Atsuo Itakura; Akihide Ohkuchi; Makoto Maeda; Norimasa Sagawa; Akihito Nakai; Soromon Kataoka; Keiya Fujimori; Yoshiki Kudo; Tomoaki Ikeda; Hisanori Minakami
Journal:  BMC Pregnancy Childbirth       Date:  2015-12-14       Impact factor: 3.007

8.  Hypertensive disorders of pregnancy: Case definitions & guidelines for data collection, analysis, and presentation of immunization safety data.

Authors:  Caroline E Rouse; Linda O Eckert; Blair J Wylie; Deirdre J Lyell; Arundhathi Jeyabalan; Sonali Kochhar; Thomas F McElrath
Journal:  Vaccine       Date:  2016-07-15       Impact factor: 3.641

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.